PASITHEA THERAPEUTICS CORP. Proceeds from Sale of Other Assets
PASITHEA THERAPEUTICS CORP. (KTTA) reported Proceeds from Sale of Other Assets of $150.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2023-11-13
- PASITHEA THERAPEUTICS CORP. proceeds from sale of other assets for the quarter ending 2023-09-30 was $0.00.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 6 month | Proceeds from Sale of Other Assets 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $150.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $150.00K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |